Date:11/7/2012

8306,691  Note receivable74,867198,117Total current assets13,785,01514,316,748Property, plant and equipment, net809,231891,822Goodwill1,701,0941,701,094Intangible and other assets1,342,5841,403,173Total assets$17,637,924$18,312,837Liabilities and stockholders' equityCurrent liabilities:  Accounts payable$
925,684$
,507,695  Accrued expenses and other current liabilities849,1011,074,932Total current liabilities1,774,7852,582,627Deferred income106,094117,147Deferred lease liability23,19922,996Total liabilities1,904,0782,722,770Commitments and contingenciesStockholders' equity:  Capital stock, $0.01 par value - shares authorized
20,000,000, 7,082,920 shares issued and
7,005,360 shares outstanding70,82970,829  Additional paid-in capital26,231,89626,132,951  Accumulated deficit(10,157,886)(10,202,720)  Treasury stock, at cost, 77,560 shares(410,993)(410,993)Total stockholders' equity15,733,84615,590,067Total liabilities and stockholders' equity$17,637,924$18,312,837

'/>"/>

SOURCE Misonix, Inc. Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Misonix Announces New Distribution Agreement For Panama
2. Misonix And SIAD Healthcare Renew Distribution Agreement For Italy
3. Misonix Exhibits at Major Worldwide Spine Conference
4. Misonix Adds Industry Veteran To Management Team
5. Misonix Participates In Cleveland Spine Review
6. Misonix And Soelim Create New Distribution Alliance For South Korea
7. Misonix Inks New Distribution Agreement For Croatia And Slovenia
8. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
9. Misonix Adds 6 Spine Sales Agencies In The U.S.
10. Misonix Product Featured At Neurosurgery Congress
11. Misonix Reports Strong Revenue Increases for the Three Months and Full-Year Ended June 30, 2012